Golden
Aphea.Bio

Aphea.Bio

A synthetic biology company making agricultural biologicals.

Aphea.Bio is a synthetic biology company making agricultural biologicals that is headquartered in Ghent, Belgium and was founded in 2017 by Isabel Vercauteren. The company spun out of the Vlaams Instituut voor Biotechnologie (VIB) life sciences research institute and its partner universities UGent and KU Leuven.

The companies products are synthetically made naturally occurring substances produced in nature by microorganisms and plants that improve the health and yield of crops. Aphea.Bio is focused on developing biocontrol and biostimulant products for wheat and maize using their research and development platform capable of strain identification, strain isolation, strain validation, and product development.

Funding

Series A

On June 26, 2017 Aphea.Bio completed their series A funding round with $10 million in funding from V-Bio Ventures (lead investor), PMV, Agri Investment Fund, VIVES, Qbic II, Gemma Frisius Fund KU Leuven, Group De Ceuster and Vlaams Instituut voor Biotechnologie (VIB). Part of the companies series A funding round came from a local research and development grant; €7.7 million came from investors.

Timeline

June 26, 2017

Aphea.Bio raises a $10,000,000 series A round from Gemma Frisius Fund, Qbic Fund, VIVES, V-Bio Ventures, Group De Ceuster, PMV Capital and Agri Investment Fund.

Funding rounds

1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn
+ Add new row

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References